New publication about the treatment of focal-onset seizures (FOS) in patients with drug resistant epilepsy (DRE) in Spain

//New publication about the treatment of focal-onset seizures (FOS) in patients with drug resistant epilepsy (DRE) in Spain

New publication about the treatment of focal-onset seizures (FOS) in patients with drug resistant epilepsy (DRE) in Spain

We are very pleased to share a new publication of which OMAKASE is a co-author together with expert Spanish epileptologists: a study to identify key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug resistant epilepsy (DRE) in Spain using MCDA methodology.

DRE presents numerous and important unmet needs. We hope this study will contribute to raise disease awareness across all stakeholders, providing a snapshot of what represents value in the treatment of FOS in DRE and provide a useful resource to determine relative drug value contribution and for decision-making.

The study has been published in Epilepsy & Behavior and can be downloaded here.

#drugresistantepilepsy #focalonsetseizures #MCDA #Spain

Villanueva V et al. Epilepsy and behaviour (2021)

2021-10-06T18:08:25+00:00October 6th, 2021|Articles|